InSitu Biologics’ co-founder and medical adviser Dan Sipple has been featured by his alma mater Des Moines University. Click here to […]
InSitu Biologics’ co-founder and medical adviser Dan Sipple has been featured by his alma mater Des Moines University. Click here to […]
Thank you to LGM Pharma for including InSitu Biologics in a recent Client Feature! We have recently shifted management of our supply chain to LGM Pharma, including […]
WOODBURY, Minn., Dec. 4, 2018 /Press Release/ — InSitu Biologics, Inc., an emerging biotech company focusing on the development of AnestaGel™, has received over $2 million in […]